• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
The pre-analytical process management status and influencing factors of laboratory test before prescribing antimicrobial in developing country.发展中国家处方前抗菌药物检验前过程管理现状及影响因素
BMC Health Serv Res. 2023 Mar 25;23(1):283. doi: 10.1186/s12913-023-09243-8.
2
The Sample Error Pre-Antimicrobial Susceptibility Testing and Its Influencing Factors from the Perspective of Hospital Management: A Cross-Sectional Study.从医院管理角度看抗菌药物敏感性试验前的样本误差及其影响因素:一项横断面研究
Antibiotics (Basel). 2022 Nov 28;11(12):1715. doi: 10.3390/antibiotics11121715.
3
Clinicians' Intention to Submit Microbiological Pathogenic Test Before Antibiotics Use and Its Influencing Factors: New Evidence from the Perspective of Hospital Management.临床医生在使用抗生素前提交微生物病原学检测的意愿及其影响因素:来自医院管理视角的新证据
Infect Drug Resist. 2022 Jun 11;15:3013-3023. doi: 10.2147/IDR.S366892. eCollection 2022.
4
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.在流行地区,服用抗叶酸抗疟药物的人群中,叶酸补充剂与疟疾易感性和严重程度的关系。
Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217.
5
Rapid antimicrobial susceptibility tests for sepsis; the road ahead.快速抗菌药敏试验在脓毒症中的应用;前路漫漫。
J Med Microbiol. 2019 Jul;68(7):973-977. doi: 10.1099/jmm.0.000997. Epub 2019 May 30.
6
A national cross-sectional study on socio-behavioural factors that influence physicians' decisions to begin antimicrobial therapy.一项关于影响医生开始抗菌治疗决策的社会行为因素的全国性横断面研究。
Infection. 2011 Aug;39(4):289-97. doi: 10.1007/s15010-011-0137-1. Epub 2011 Jun 30.
7
[Evaluation of Pre-analytical Process with Quality Indicators and Six Sigma Methodology in the Parasitology Laboratory of a Tertiary Healthcare Center].[三级医疗中心寄生虫学实验室中使用质量指标和六西格玛方法对分析前过程的评估]
Mikrobiyol Bul. 2019 Jul;53(3):319-329. doi: 10.5578/mb.68362.
8
A cross-sectional survey of antimicrobial stewardship strategies in UK hospitals.英国医院抗菌药物管理策略的横断面调查。
J Clin Pharm Ther. 2014 Oct;39(5):516-20. doi: 10.1111/jcpt.12181. Epub 2014 May 29.
9
Pre-analytical workstations: a tool for reducing laboratory errors.分析前工作站:一种减少实验室误差的工具。
Clin Chim Acta. 2009 Jun;404(1):68-74. doi: 10.1016/j.cca.2009.03.024. Epub 2009 Mar 18.
10
Point prevalence survey of antimicrobial prescription in a tertiary hospital in South East Nigeria: A call for improved antibiotic stewardship.尼日利亚东南部一家三级医院抗菌药物处方的现况调查:呼吁加强抗生素管理。
J Glob Antimicrob Resist. 2019 Jun;17:291-295. doi: 10.1016/j.jgar.2019.01.013. Epub 2019 Jan 19.

引用本文的文献

1
Factors Influencing Clinicians' Use of Hospital Information Systems for Infection Prevention and Control: Cross-Sectional Study Based on the Extended DeLone and McLean Model.影响临床医生使用医院信息系统进行感染预防和控制的因素:基于扩展的德洛恩和麦克莱恩模型的横断面研究。
J Med Internet Res. 2023 Jun 22;25:e44900. doi: 10.2196/44900.

本文引用的文献

1
COVID-19 and antimicrobial resistance: A cross-study.新型冠状病毒肺炎与抗菌药物耐药性:一项跨研究分析。
Sci Total Environ. 2022 Feb 10;807(Pt 2):150873. doi: 10.1016/j.scitotenv.2021.150873. Epub 2021 Oct 8.
2
Barriers to implementing antimicrobial stewardship programs in three low- and middle-income country tertiary care settings: findings from a multi-site qualitative study.在三个中低收入国家三级保健机构实施抗菌药物管理计划的障碍:一项多地点定性研究的结果。
Antimicrob Resist Infect Control. 2021 Mar 25;10(1):60. doi: 10.1186/s13756-021-00929-4.
3
Integrating antibiotic stewardship and infection prevention and control programs using a team science approach.采用团队科学方法整合抗生素管理和感染预防与控制计划。
Am J Infect Control. 2021 Aug;49(8):1072-1074. doi: 10.1016/j.ajic.2021.01.020. Epub 2021 Jan 29.
4
Evaluation of bacterial co-infections of the respiratory tract in COVID-19 patients admitted to ICU.评估 ICU 收治的 COVID-19 患者呼吸道的细菌合并感染。
BMC Infect Dis. 2020 Sep 1;20(1):646. doi: 10.1186/s12879-020-05374-z.
5
Tackling antimicrobial resistance in the COVID-19 pandemic.应对新冠疫情中的抗菌药物耐药性问题。
Bull World Health Organ. 2020 Jul 1;98(7):442-442A. doi: 10.2471/BLT.20.268573.
6
Digital microbiology.数字微生物学。
Clin Microbiol Infect. 2020 Oct;26(10):1324-1331. doi: 10.1016/j.cmi.2020.06.023. Epub 2020 Jun 27.
7
COVID-19: don't neglect antimicrobial stewardship principles!2019冠状病毒病:勿忽视抗菌药物管理原则!
Clin Microbiol Infect. 2020 Jul;26(7):808-810. doi: 10.1016/j.cmi.2020.04.024. Epub 2020 Apr 30.
8
Five rules for resistance management in the antibiotic apocalypse, a road map for integrated microbial management.抗生素危机中耐药性管理的五条规则,综合微生物管理路线图。
Evol Appl. 2019 May 14;12(6):1079-1091. doi: 10.1111/eva.12808. eCollection 2019 Jun.
9
Barriers and facilitators and the need for a clinical guideline for microbiological diagnostic testing in the hospital: a qualitative and quantitative study.医院微生物诊断检测的临床指南的障碍和促进因素及必要性:定性和定量研究。
Eur J Clin Microbiol Infect Dis. 2019 May;38(5):913-920. doi: 10.1007/s10096-019-03516-z. Epub 2019 Mar 7.
10
Emergence of Global Antibiotic Resistance.全球抗生素耐药性的出现
Prim Care. 2018 Sep;45(3):467-484. doi: 10.1016/j.pop.2018.05.006.

发展中国家处方前抗菌药物检验前过程管理现状及影响因素

The pre-analytical process management status and influencing factors of laboratory test before prescribing antimicrobial in developing country.

机构信息

School of Medicine and Health Management, Tongji Medical College of Huazhong University of Science and Technology, Wuhan, 430030, Hubei, China.

School of Nursing, Hong Kong Polytechnic University, Hung Hom, Kowloon, Hong Kong SAR.

出版信息

BMC Health Serv Res. 2023 Mar 25;23(1):283. doi: 10.1186/s12913-023-09243-8.

DOI:10.1186/s12913-023-09243-8
PMID:36966281
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10039769/
Abstract

INTRODUCTION

The results of laboratory testing are crucial basis for clinicians to prescribe antimicrobial. Laboratory testing is a highly complex process, and increasing evidence suggests that errors and obstacles in the pre-analytical process (PP) will affect reasonable antimicrobial use. However, PP was an easily neglected link in hospital infection management and the current situation of it and the influencing factors of management are not clear.

METHODS

A cross-sectional survey was conducted in the department of clinical, specimen collection, transportation, and inspection in 109 secondary and tertiary hospitals in Central China. The rate of antimicrobial susceptibility test request (AST) and related indexes of above departments were calculated to describe the situation. Management characteristics (frequency of training etc.) were described as proportions and fractional probit regression analysis was used to determine the influencing factors.

RESULTS

The average rate of non restricted-use antimicrobial was 63%, the restricted-use was 86%, the special-use was 95%. The zero obstacle rate of specimen collection was 27.3%, of specimen transportation was 19.4% and of inspection feedback was 61.7%. There was a difference between the secondary and tertiary hospitals on non restricted-use (X = 22.968, P < 0.001); restricted-use (X = 29.466, P < 0.001); special-use (X = 27.317, P < 0.001). Taking non restricted-use as an example, training (OR = 0.312, 95%CI: 0.148,0.429), low-frequency appraisal (OR = 0.153, 95%CI: 0.082,0.224), guidance (OR = 0.32, 95%CI: 0.237,0.403) and information technology (OR = 0.104, 95%CI: 0.009,0.199) were positive factors.

CONCLUSIONS

There were substantial differences in the rate of AST request in clinical department between secondary and tertiary hospitals. The zero obstacle rate in collection, transportation and inspection department were still low. In most departments, training and performance appraisal were positive factors, guidance and information technology were positive supporting factors.

摘要

简介

实验室检测结果是临床医生开具抗菌药物的重要依据。实验室检测是一个高度复杂的过程,越来越多的证据表明,分析前过程(PP)中的错误和障碍会影响合理使用抗菌药物。然而,PP 是医院感染管理中容易被忽视的环节,目前其现状及管理的影响因素尚不清楚。

方法

采用横断面调查方法,对华中地区 109 家二级和三级医院的临床科室、标本采集、运输和检验部门进行调查。计算各科室抗菌药物敏感性试验申请(AST)率及相关指标,描述现状。以培训频率等管理特征为例,描述比例,并采用分数概率回归分析确定影响因素。

结果

非限制使用抗菌药物的平均使用率为 63%,限制使用抗菌药物的使用率为 86%,特殊使用抗菌药物的使用率为 95%。标本采集零障碍率为 27.3%,标本运输零障碍率为 19.4%,检验反馈零障碍率为 61.7%。二级和三级医院在非限制使用(X²=22.968,P<0.001)、限制使用(X²=29.466,P<0.001)、特殊使用(X²=27.317,P<0.001)方面存在差异。以非限制使用为例,培训(OR=0.312,95%CI:0.148,0.429)、低频率评估(OR=0.153,95%CI:0.082,0.224)、指导(OR=0.32,95%CI:0.237,0.403)和信息技术(OR=0.104,95%CI:0.009,0.199)是正相关因素。

结论

临床科室 AST 请求率在二级和三级医院之间存在较大差异。采集、运输和检验部门的零障碍率仍较低。在大多数科室,培训和绩效考核是正相关因素,指导和信息技术是正相关的支持因素。